Female Health Medicines

Leading Wholesale Distributor of clomifene citrate 50mg tablets clofi 50, tranexaheal 500 mg tablet and oxynine 5 mg tablet from Nagpur.

Clomifene Citrate 50mg Tablets clofi 50

Request Callback

₹ 83 / Strip Get Latest Price

Strength50 mg
FormTablet
Packaging TypeStrip
Dose Strength50mg
Packaging Size10 X 10 tablets
Product TypeFinished Product
CompositionComifene citrate 50mg
Manufactured BySunrise

Minimum order quantity: 10 Strip

Clomiphene is used in the treatment of female infertility. It works well for women who cannot get pregnant due to the problem with ovulation (release of an egg).Clomiphene is a selective estrogen receptor modulator (SERM) which treats female infertility

TRANEXAHEAL 500 MG TABLET

Request Callback

₹ 100 / Box Get Latest Price

Strength500 mg
Packaging TypeStripe
Packaging Size10*10 Tablets
BrandTRANEXAHEAL 500MG
ManufacturerHEALING PHARMA
Shelf Life36 MONTHS
FORMTABLET

Minimum order quantity: 10 Box

Tranexaheal 500 Tablet 10 is used to manage excessive bleeding due to heavy menstrual periods, nosebleeds, or bleeding after surgery. It contains tranexamic acid, which helps reduce abnormal bleeding by stabilising blood clots. It belongs to a class of medicines referred to as antifibrinolytics.

OXYNINE 5 MG TABLET

Request Callback

₹ 200 / Strip Get Latest Price

Strength5 mg
Packaging TypeStripe
Packaging Size10*10
BrandJOHNLEE
ManufacturerJOHNLEE PHARMACEUTICAL PVT LTD
Shelf life36 MONTHS
COMPOSITIONOxybutynin (5mg)
Oxybutynin is used to treat symptoms of an overactive bladder, such as incontinence (loss of bladder control) or a frequent need to urinate. Oxybutynin belongs to the group of medicines called antispasmodics. It helps decrease muscle spasms of the bladder and the frequent urge to urinate caused by these spasms.
X

Contact Us

Sangeeta Pramod Deshmukh (CEO)
Ira Exim
Plot No. 33a, Block No.1, Bansod Layout, Besa Beltarodi Road, Near Saflya Nagari, Opposite Of D, Mart
Besa Road, Nagpur - 440037, Maharashtra, India

Get Directions
Send Email
Share: